4//SEC Filing
HALAS GUS D 4
Accession 0001213900-21-051140
CIK 0001448431other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:45 PM ET
Size
5.7 KB
Accession
0001213900-21-051140
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
HALAS GUS D
Director
Transactions
- Award
Restricted Stock Units
2021-09-29+334→ 334 total→ Common Stock (334 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on September 29, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction.
- [F3]Not applicable.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001230322
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:45 PM ET
- Size
- 5.7 KB